Where can I buy Medicare leads?

Why Buying Medicare Leads Requires More Than Just a Vendor List

Purchasing Medicare leads isn't just about finding a vendor list—it's about navigating a complex landscape where compliance, timing, and lead quality directly impact your success. Generic lead buying often fails because it overlooks critical factors like CMS regulations, contact speed, and lead exclusivity, leaving agents with low conversion rates and regulatory risk.

The CMS 1:1 opt-in rule has fundamentally reshaped Medicare lead generation by requiring explicit, documented consent for each beneficiary interaction, eliminating bulk reselling and increasing lead quality despite higher per-lead costs. This shift means leads sourced without proper consent records expose agents to compliance risks, including potential sanctions from CMS, even if unintentional. As noted in industry insights, explicit consent is now non-negotiable—blanket permissions and pre-checked boxes no longer meet regulatory standards, making consent documentation essential for every lead purchased.

Speed-to-lead is equally critical, with research showing that contacting a lead within five minutes makes engagement roughly 100 times more likely than waiting thirty minutes, and 78% of buyers choosing the agent who responds first. Delayed follow-up drastically reduces contact rates, turning high-intent leads into missed opportunities. Furthermore, shared lead models—where the same lead is sold to multiple agents—intensify competition and lower conversion odds, especially when leads are resold to five or more buyers as seen in some marketplaces.

GrowthPros addresses these challenges by delivering leads as a product with built-in compliance and speed: every lead includes a consent record with disclosure text, timestamp, IP address, and the named contacting party, ensuring adherence to CMS 1:1 opt-in rules. Leads are DNC-scrubbed before contact, and opt-outs are honored permanently across all channels. Additionally, their capped-shared model limits distribution to a hard maximum of two buyers—never five—reducing direct competition while maintaining cost efficiency. Each lead triggers AI-powered voice, SMS, and email follow-up within a five-minute window, 24/7, maximizing contact likelihood at the peak of lead freshness. This process ensures agents receive qualified, time-stamped leads with full consent trails, ready for immediate engagement in their CRM.

How GrowthPros Solves the Core Problems in Medicare Lead Purchasing

Many Medicare lead buyers face persistent frustration: leads that feel stale, shared too widely, or arrive without proof of consent—undermining both compliance and conversion. GrowthPros addresses these core pain points by treating leads as a qualified product, not a commodity, with systems built for speed, exclusivity, and documented consent.

Every lead delivered by GrowthPros includes a verified consent record—disclosure text, timestamp, IP address, and the named contacting party—ensuring adherence to CMS’s one-to-one opt-in rule, which research shows lowers cost per enrollment by 20–35% despite higher per-lead costs. This compliance-first approach eliminates the risk of shared consent models that carry high regulatory exposure and weak enrollment results. Leads are never dumped into a shared inbox; instead, exclusive leads go to one buyer, and capped-shared leads are strictly limited to two buyers—never the five or more common on other platforms.

Speed-to-lead is embedded in the delivery process: AI-powered voice, SMS, and email follow-up occurs within five minutes of lead generation or reactivation. Data confirms that contacting a lead within five minutes makes qualification roughly 100x more likely than waiting thirty minutes, and 78% of buyers choose the agent who responds first. This rapid engagement is not an add-on—it’s included with every lead, ensuring timely outreach when intent is highest.

Leads land CRM-ready via webhook, Zapier, or native integration into platforms like Salesforce, HubSpot, and Follow Up Boss, each accompanied by its full consent trail. For clients with dormant opted-in lists, GrowthPros’ dead lead reactivation service re-engages 8–15% of inactive contacts through a multi-channel AI sequence—starting with SMS, then voice, then email—returning qualified prospects directly into the client’s workflow.

• Exclusive leads close 15–30% higher than shared leads, though they cost 2–4x more per lead.
• One-to-one consent leads reduce cost per acquisition by 20–35% despite higher upfront cost.
• Contacting leads within five minutes increases qualification likelihood by up to 100x compared to 30-minute delays.

By combining verified consent, hard caps on sharing, and AI-driven speed-to-lead, GrowthPros turns lead purchasing from a compliance gamble into a predictable, high-intent pipeline—where every contact starts with trust and timing on your side.

The Exact Process to Buy and Activate Medicare Leads with GrowthPros

Buying Medicare leads shouldn't feel like a gamble on vague promises and recycled data. GrowthPros treats leads as a product, not a service — every lead is qualified, time-stamped, and consent-recorded before it ever reaches your inbox, and the process starts with a single 15-minute conversation.

Step 1: The qualification call. There's no self-serve checkout. A 15-minute qualification call sets real numbers based on your niche, territory, and volume needs — whether you're buying exclusive leads, reviving a dormant list, or both. This matters in Medicare, where CMS's tightened marketing rules mean explicit, documented consent is now non-negotiable, and blanket permissions or pre-checked boxes are no longer acceptable.

Step 2: Niche selection and sourcing. Once your niche and goal are defined, GrowthPros sources fresh exclusive leads — DNC-scrubbed and consent-recorded before any outbound contact. You choose between exclusive leads, which cost 2–4x a shared lead but close 15–30% higher, or capped-shared leads that go to a hard maximum of two buyers — never five, unlike shared marketplaces where you compete against numerous other agents for the same prospect.

Step 3: AI follow-up within five minutes. Every delivered lead gets AI voice, SMS, and email follow-up inside a five-minute window, 24/7 — included with every lead, not an upsell. The math behind that window is stark: contacting a lead within five minutes makes contact roughly 100x more likely than at thirty minutes, and about 78% of buyers choose whoever responds first. Research on Medicare leads echoes this — if you're not reaching out within 5–10 minutes, your lead is already losing interest.

Step 4: CRM delivery. Leads land where your team already works:

• Native integrations into Salesforce, HubSpot, Follow Up Boss, ServiceTitan, and most other platforms
• Webhook or Zapier delivery for custom stacks
• A provisioned CRM ready the same day, with exportable data

Each lead arrives with its consent trail attached — disclosure text, timestamp, IP address, and the named contacting party — so your license is never carrying someone else's compliance risk. That documentation matters: CMS can impose sanctions on agents who use lead sources that violate marketing rules, even if the agent was unaware of the violation.

The same pipeline applies to dead lead reactivation. If you have a dormant, opted-in CRM list, a multi-channel AI sequence (SMS first, voice follow-up, email backup) typically re-engages 8–15% of the database, at 60–80% below new-lead cost.

The call is free, honest about fit, and commits you to nothing — the promise is the process, not a guaranteed close.